| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8723960 | Osteoporosis and Sarcopenia | 2018 | 8 Pages |
Abstract
Monthly minodronate treatment increases BMD and reduces bone metabolism markers. The effect lessens after treatment interruptions, and can be restored by retreatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Nobukazu Okimoto, Shinobu Arita, Shojiro Akahoshi, Kenji Baba, Shito Fukuhara, Toru Ishikura, Toru Yoshioka, Yoshifumi Fuse, Ken Okamoto, Kunitaka Menuki, Akinori Sakai,